Innovations

Worldwide, an estimated 19.3 million new cancer cases and nearly 9.9 million cancer deaths occurred in 2020. While cancer incidence rates tend to be lower in low- and middle-income countries (LMIC) compared with high-income countries (HIC), the population sizes tend to be larger, resulting in a higher absolute number of patients with cancer.

Ultrasonography is often the preferred method of imaging for needle-guided procedures of the hip joint, including aspirations, local anaesthetic injections, and the use of corticosteroids. Phantoms (i.e., training devices mimicking human tissue and bony structures under acoustic sonography) are used to help train medical professionals to perform these procedures accurately, emphasising the art of physical simulation in unison with didactic learning.

In 2017, colorectal cancer (CRC) accounted for 13% of new malignancy diagnoses in Canada. It is the second leading cause of cancer-related deaths in Canadian males, and the third leading cause of cancer related deaths in Canadian females.

The scientific community has made great strides in responding to the huge public health problems of obesity and diabetes with the discovery of the incretin system and the development of glucagon-like peptide 1 analogues.

Yann Le Cam Chief | Executive Officer, EURORDIS-Rare Diseases Europe. The conference happens every 2 years and the purpose is to formulate strategies at a national, international, and European level. The conference also provides an opportunity to look at legislative and non-legislative policies and learn about the latest research. The scope is broad, covering the entire spectrum of rare diseases.

Rare diseases are individually rare but collectively common, with a combined prevalence of 3.5–5.9%. A common feature of many diseases is a substantial delay in patients receiving a correct diagnosis; this protracted path to diagnosis is termed ‘the diagnostic odyssey’.

The urgent need regarding people with a rare disease in Ukraine is for help to get vulnerable families safely out of the country and help…

Martin O. Savage  – Professor Emeritus in Paediatric Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry; Professor of Paediatric Endocrinology, London Clinic Centre for Endocrinology; Professor, Queen Mary University London, UK.